Last updated on January 2019

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Clinical Study Identifier: NCT03518073

Contact Investigators or Research Sites near you

Start Over

Jennifer Ingram

Kawartha Regional Memory Clinic
Peterborough, ON Canada
0.16miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.